Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bernie Sanders demands Ozempic producer to ‘stop ripping us off’ in Senate hearing
Senators grilled Novo Nordisk CEO Lars Jorgensen at a hearing on Tuesday about the cost of diabetes drug Ozempic and weight loss medication Wegovy, both of which are often prohibitively expensive in the United States despite their life-saving potential.
Sen. Bernie Sanders grills maker of Ozempic
On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.
Elon Musk and Bernie Sanders say they agree on one thing—cheaper Ozempic
Novo Nordisk is investing $30 billion to expand production, but middlemen are pocketing 74 cents of every dollar it makes in sales.
‘Greed, greed, greed’: Sanders demands Ozempic maker lower prices
While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, on Tuesday, Sen. Bernie Sanders alleged that 40,000 people a year in the US could die if the company doesn’t make the medicines more affordable.
Bernie Sanders grills Novo Nordisk CEO on price of Ozempic, other weight-loss drugs
Sen. Bernie Sanders grilled Novo Nordisk's CEO Lars Jorgensen over the cost of the company's weight loss and diabetes medications, Ozempic and Wegovy.
Sen. Bernie Sanders grills maker of Ozempic over sky-high U.S. prices
The maker of diabetes and weight-loss drugs Ozempic and Wegovy was in the hot seat Tuesday as Vermont Sen. Bernie Sanders grilled him about high prices in the U.S. that far exceed the cost in
Sanders quizes Ozempic CEO over high prices in tense hearing
What I am asking you is, if you don’t act, 40,000 people a year could die? Is this acceptable to you?” the senator asked.
Sanders says PBMs won’t penalize Novo for cutting Ozempic, Wegovy prices
WASHINGTON — Senate health committee chair Bernie Sanders said major drug middlemen have agreed not to limit coverage of Novo Nordisk’s Ozempic and Wegovy if the company lowers the prices of the treatments. It’s Sanders’ latest move to pressure Novo to cut the prices of the blockbuster diabetes and obesity therapies.
Sanders, Novo Nordisk CEO clash over Ozempic, Wegovy drug prices
The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite repeatedly being pressed by Sen. Bernie Sanders (I-Vt.), chair of the
Ozempic, Wegovy maker grilled by Bernie Sanders-led committee over high prices
The Senate Health, Education, Labor and Pension committee, led by Vermont Sen. Bernie Sanders, is hearing testimony from Novo Nordisk CEO Lars Fruergaard Jørgensen on the exhortative prices for their drugs in the U.
9d
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
Ozempic is a popular diabetes drug that is also used for weight loss by suppressing appetite. Sanders expressed confidence ...
Mediaite
6d
Bernie Sanders Agrees with Elon Musk on ‘Solving Obesity’ With Government-Funded Ozempic
Sanders found unlikely common ground with pro-Trump Elon Musk, citing the tech mogul as “right” on “solving obesity” in a ...
6d
on MSN
Elon Musk and Bernie Sanders agree on one thing: Ozempic
The health benefits of blockbuster weight loss drugs are bridging the stark political divide in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Walz-Vance VP debate
Iran launches missile attack
Helene wreaks havoc
US warns foreign operators
'Good Times' star dies
Sworn in as Mexico's pres
120 new assault allegations
Files for bankruptcy
Pledges support for Ukraine
FL homeless law kicks in
Suspended five games
CA sues Catholic hospital
Sex offender registry ruling
3.5 quake rattles SoCal
November trial set
US new vehicle sales fall
Michel sues Hill for fraud
MS-13 associate sentenced
Breast cancer deaths fall
Top Adams aide resigns
US job openings rebound
Arkansas sues YouTube
Tulsa Race Massacre probe
Gonzaga set to join PAC-12
Broadway star dies at 70
US sanctions settler group
DOJ report on GA prisons
'Pled guilty to journalism'
Kentucky sheriff steps down
Feedback